Olfr826 Inhibitors
Olfr826 is a member of the olfactory receptor family, specifically classified as a G-protein-coupled receptor (GPCR). These receptors are pivotal in the detection of odorant molecules and are essential for the olfactory signal transduction pathway, ultimately leading to the perception of smell. The functionality of Olfr826, similar to other olfactory receptors, is characterized by its ability to bind specific odorant molecules and initiate intracellular signaling crucial for olfactory processing. The direct inhibitors of Olfr826 are not well-established, necessitating a focus on indirect inhibitors. These inhibitors exert their effects by influencing various regulatory mechanisms and pathways associated with olfactory receptor function. The modulation of these pathways can alter the activity, expression, or signaling efficiency of Olfr826, thereby serving as a means of indirect inhibition.
The chemicals listed in the table target various aspects of cellular function and signaling pathways that could indirectly impact Olfr826. For instance, compounds that affect neurotransmitter signaling, such as dopamine, serotonin, and GABA, can modify the neuronal environment and thus influence the function of olfactory receptors like Olfr826. Others, acting on metabolic or hormonal pathways, can change the cellular context, which may affect receptor expression or signaling. The inhibition of Olfr826 by these chemicals occurs through broader cellular or systemic mechanisms rather than direct interaction with the receptor. This understanding of potential indirect inhibitors is crucial for comprehending the complex regulation of olfactory receptors. It highlights the diverse strategies that might be employed to modulate the activity of receptors like Olfr826.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol, a dopamine antagonist, reduces dopaminergic signaling. This might indirectly inhibit Olfr826 by affecting dopamine's modulatory role in olfactory transduction pathways. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol, a xanthine oxidase inhibitor, reduces uric acid production. This can indirectly inhibit Olfr826 by altering purinergic signaling, potentially impacting olfactory receptor function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Sodium Valproate, a histone deacetylase inhibitor, alters gene expression. Indirect inhibition of Olfr826 might occur through changes in the expression of genes involved in olfactory receptor regulation. | ||||||
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Donepezil, an acetylcholinesterase inhibitor, enhances cholinergic transmission. This could indirectly inhibit Olfr826 by influencing acetylcholine's regulatory effects on olfactory neurons. | ||||||
Topiramate | 97240-79-4 | sc-204350 sc-204350A | 10 mg 50 mg | $107.00 $369.00 | ||
Topiramate, a GABA receptor modulator, affects neuronal excitability. This might indirectly inhibit Olfr826 by modulating GABAergic control in olfactory receptor neurons. | ||||||
Risperidone | 106266-06-2 | sc-204881 sc-204881A sc-204881B sc-204881C | 10 mg 50 mg 1 g 5 g | $174.00 $719.00 $1020.00 $2040.00 | 1 | |
Risperidone, a serotonin-dopamine antagonist, modulates neurotransmitter signaling. Its indirect inhibition of Olfr826 could result from altered neurotransmitter dynamics affecting olfactory receptors. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol, an estrogen hormone, modulates gene expression. This could indirectly inhibit Olfr826 by affecting hormonal regulation of olfactory receptor expression. | ||||||
(S)-Timolol Maleate | 26921-17-5 | sc-203297 sc-203297A | 100 mg 250 mg | $61.00 $126.00 | ||
Timolol, a beta-blocker, reduces adrenergic signaling. Indirect inhibition of Olfr826 might occur through the modulation of adrenergic influence on olfactory transduction. | ||||||
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $70.00 $112.00 | 4 | |
Methimazole, a thyroid inhibitor, affects thyroid hormone levels. This can indirectly inhibit Olfr826 by influencing thyroid hormone-mediated regulation of olfactory receptor expression. | ||||||
Aripiprazole | 129722-12-9 | sc-207300 sc-207300A sc-207300B | 100 mg 1 g 5 g | $179.00 $212.00 $1037.00 | 3 | |
Aripiprazole, a dopamine-serotonin system stabilizer, modulates neurotransmitter activity. Its potential to indirectly inhibit Olfr826 lies in altering the neurotransmitter environment affecting olfactory pathways. | ||||||